Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20020077524 A1
Publication typeApplication
Application numberUS 10/073,968
Publication dateJun 20, 2002
Filing dateFeb 14, 2002
Priority dateJan 2, 1997
Also published asCA2275766A1, CA2275766C, DE69737955T2, EP1011461A1, EP1011461A4, EP1011461B1, US6050936, US6059715, US6162168, US6165119, US6165120, US6332863, US6332864, US6514194, US6589160, US6755777, US6793618, US7695425, US20020058855, US20020068849, US20030166992, US20030171641, US20040167374, US20090137863, WO1998029041A1
Publication number073968, 10073968, US 2002/0077524 A1, US 2002/077524 A1, US 20020077524 A1, US 20020077524A1, US 2002077524 A1, US 2002077524A1, US-A1-20020077524, US-A1-2002077524, US2002/0077524A1, US2002/077524A1, US20020077524 A1, US20020077524A1, US2002077524 A1, US2002077524A1
InventorsCyril Schweich, Todd Mortier
Original AssigneeMyocor, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Heart wall tension reduction apparatus
US 20020077524 A1
Abstract
An apparatus for treatment of a failing heart by reducing the wall tension therein. In one embodiment, the apparatus includes a tension member for drawing at least two walls of a heart chamber toward each other.
Images(4)
Previous page
Next page
Claims(14)
What is claimed is:
1. An apparatus for the treatment of a failing heart, comprising:
means for reducing the cross sectional area of the heart in at least one plane.
2. The apparatus of claim 1, wherein the means includes a tension member for drawing at least two walls of the heart chamber toward each other.
3. The apparatus of claim 1, wherein the means includes a compression member for urging at least two walls of the heart chamber toward each other.
4. The apparatus in accordance with claim 3, wherein the compression member includes a balloon.
5. The apparatus in accordance with claim 3, wherein the means further comprises a frame for supporting the compression member.
6. The apparatus in accordance with claim 1, wherein the means includes a clamp.
7. An apparatus for reducing the tension in the wall of the heart chamber in at least one cross sectional plane, comprising:
a draw member having first and second ends; and
anchoring means disposed at each end of the draw member for engagement with the chamber wall.
8. An apparatus in accordance with claim 7, wherein the draw member includes a tension member.
9. The apparatus in accordance with claim 7, wherein the draw member includes a clamp.
10. The apparatus in accordance with claim 9, wherein the anchor members are biased toward each other.
11. An apparatus for reducing the tension in the wall of a heart chamber in at least one cross sectional plane, comprising:
a compression member having an atraumatic surface for placement against the exterior of the heart.
12. The apparatus in accordance with claim 11, wherein the compression member includes a balloon.
13. The apparatus in accordance with claim 11, further comprising a frame for supporting the compression member.
14. The apparatus in accordance with claim 13, wherein the frame includes means for attachment of the frame to the heart.
Description
    FIELD OF THE INVENTION
  • [0001]
    The present invention pertains to the field of apparatus for treatment of a failing heart. In particular, the apparatus of the present invention is directed toward reducing the wall stress in the failing heart.
  • BACKGROUND OF THE INVENTION
  • [0002]
    The syndrome of heart failure is a common course for the progression of many forms of heart disease. Heart failure may be considered to be the condition in which an abnormality of cardiac function is responsible for the inability of the heart to pump blood at a rate commensurate with the requirements of the metabolizing tissues, or can do so only at an abnormally elevated filling pressure. There are many specific disease processes that can lead to heart failure with a resulting difference in pathophysiology of the failing heart, such as the dilatation of the left ventricular chamber. Etiologies that can lead to this form of failure include idiopathic cardiomyopathy, viral cardiomyopathy, and ischemic cardiomyopathy.
  • [0003]
    The process of ventricular dilatation is generally the result of chronic volume overload or specific damage to the myocardium. In a normal heart that is exposed to long term increased cardiac output requirements, for example, that of an athlete, there is an adaptive process of slight ventricular dilation and muscle myocyte hypertrophy. In this way, the heart fully compensates for the increased cardiac output requirements. With damage to the myocardium or chronic volume overload, however, there are increased requirements put on the contracting myocardium to such a level that this compensated state is never achieved and the heart continues to dilate.
  • [0004]
    The basic problem with a large dilated left ventricle is that there is a significant increase in wall tension and/or stress both during diastolic filling and during systolic contraction. In a normal heart, the adaptation of muscle hypertrophy (thickening) and ventricular dilatation maintain a fairly constant wall tension for systolic contraction. However, in a failing heart, the ongoing dilatation is greater than the hypertrophy and the result is a rising wall tension requirement for systolic contraction. This is felt to be an ongoing insult to the muscle myocyte resulting in further muscle damage. The increase in wall stress is' also true for diastolic filling. Additionally, because of the lack of cardiac output, there is generally a rise in ventricular filling pressure from several physiologic mechanisms. Moreover, in diastole there is both a diameter increase and a pressure increase over normal, both contributing to higher wall stress levels. The increase in diastolic wall stress is felt to be the primary contributor to ongoing dilatation of the chamber.
  • [0005]
    Prior art treatments for heart failure fall into three generally categories. The first being pharmacological, for example, diuretics. The second being assist systems, for example, pumps. Finally, surgical treatments have been experimented with, which are described in more detail below.
  • [0006]
    With respect to pharmacological treatments, diuretics have been used to reduce the workload of the heart by reducing blood volume and preload. Clinically, preload is defined in several ways including left ventricular end diastolic pressure (LVEDP), or left ventricular end diastolic volume (LVEDV). Physiologically, the preferred definition is the length of stretch of the sarcomere at end diastole. Diuretics reduce extra cellular fluid which builds in congestive heart failure patients increasing preload conditions. Nitrates, arteriolar vasodilators, angiotensin converting enzyme inhibitors have been used to treat heart failure through the reduction of cardiac workload through the reduction of afterload. Afterload may be defined as the tension or stress required in the wall of the ventricle during ejection. Inotropes like digoxin are cardiac glycosides and function to increase cardiac output by increasing the force and speed of cardiac muscle contraction. These drug therapies offer some beneficial effects but do not stop the progression of the disease.
  • [0007]
    Assist devices include mechanical pumps and electrical stimulators. Mechanical pumps reduce the load on the heart by performing all or part of the pumping function normally done by the heart. Currently, mechanical pumps are used to sustain the patient while a donor heart for transplantation becomes available for the patient. Electrical stimulation such as bi-ventricular pacing have been investigated for the treatment of patients with dilated cardiomyopathy.
  • [0008]
    There are at least three surgical procedures for treatment of heart failure: 1) heart transplant; 2) dynamic cardiomyoplasty; and 3) the Batista partial left ventriculectomy. Heart transplantation has serious limitations including restricted availability of organs and adverse effects of immunosuppressive therapies required following heart transplantation. Cardiomyoplasty includes wrapping the heart with skeletal muscle and electrically stimulating the muscle to contract synchronously with the heart in order to help the pumping function of the heart. The Batista partial left ventriculectomy includes surgically remodeling the left ventricle by removing a segment of the muscular wall. This procedure reduces the diameter of the dilated heart, which in turn reduces the loading of the heart. However, this extremely invasive procedure reduces muscle mass of the heart.
  • SUMMARY OF THE INVENTION
  • [0009]
    The present invention pertains to a non-pharmacological, passive apparatus for the treatment of a failing heart. The device is configured to reduce the tension in the heart wall. It is believed to reverse, stop or slow the disease process of a failing heart as it reduces the energy consumption of the failing heart, decrease in isovolumetric contraction, increases sarcomere shortening during contraction and an increase in isotonic shortening in turn increases stroke volume. The device reduces wall tension during diastole (preload) and systole.
  • [0010]
    In one embodiment, the apparatus includes a tension member for drawing at least two walls of the heart chamber toward each other to reduce the radius or area of the heart chamber in at least one cross sectional plane. The tension member has anchoring member disposed at opposite ends for engagement with the heart or chamber wall.
  • [0011]
    In another embodiment, the apparatus includes a compression member for drawing at least two walls of a heart chamber toward each other. In one embodiment, the compression member includes a balloon. In another embodiment of the apparatus, a frame is provided for supporting. the compression member.
  • [0012]
    Yet another embodiment of the invention includes a clamp having two ends biased toward one another for drawing at least two walls of a heart chamber toward each other. The clamp includes at least two ends having atraumatic anchoring member disposed thereon for engagement with the heart or chamber wall.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • [0013]
    [0013]FIG. 1 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of a splint in accordance with the present invention;
  • [0014]
    [0014]FIG. 2 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of a balloon device in accordance with the present invention;
  • [0015]
    [0015]FIG. 3 is a transverse cross-section of the left and right ventricles of a human heart showing the placement of an external compression frame structure in accordance with the present invention;
  • [0016]
    [0016]FIG. 4 is a transverse cross-section of the left and right ventricles of a human heart showing a clamp in accordance with the present invention;
  • [0017]
    [0017]FIG. 5 is a transverse cross-section of the left and right ventricles of a human heart showing a three tension member version of the splint of FIG. 1;
  • [0018]
    [0018]FIG. 6 is a transverse cross-section of the left and right ventricles of a human heart showing a four tension member version of the splint shown in FIG. 1;
  • [0019]
    [0019]FIG. 7 is a vertical cross-section of the left ventricle and atrium, the left ventricle having scar tissue;
  • [0020]
    [0020]FIG. 8 is a vertical cross-section of the heart of FIG. 7 showing the splint of FIG. 1 drawing the scar tissue toward the opposite wall of the left ventricle;
  • [0021]
    [0021]FIG. 9 is a vertical cross-section of the left ventricle and atrium of a human heart showing a version of the splint of FIG. 1 having an elongate anchor bar;
  • [0022]
    [0022]FIG. 10 is a side view of an undeployed hinged anchor member;
  • [0023]
    [0023]FIG. 11 is a side view of a deployed hinged anchor member of FIG. 10;
  • [0024]
    [0024]FIG. 12 is a cross-sectional view of an captured ball anchor member;
  • [0025]
    [0025]FIG. 13 is a perspective view of a cross bar anchor member;
  • [0026]
    [0026]FIG. 14 is a idealized cylindrical model of a left ventricle of a human heart;
  • [0027]
    [0027]FIG. 15 is a splinted model of the left ventricle of FIG. 14;
  • [0028]
    [0028]FIG. 16 is a transverse cross-sectional view of FIG. 15 showing various modeling parameters;
  • [0029]
    [0029]FIG. 17 is a transverse cross-section of the splinted left ventricle of FIG. 15 showing a hypothetical force distribution; and
  • [0030]
    [0030]FIG. 18 is a second transverse cross-sectional view of the model left ventricle of FIG. 15 showing a hypothetical force distribution.
  • DETAILED DESCRIPTION OF THE INVENTION
  • [0031]
    Referring now to the drawings wherein like reference numerals refer to like elements throughout the several views, FIG. 1 shows a transverse cross-section of a left ventricle 10 and a right ventricle 12 of a human heart 14. Extending through the left ventricle is a splint 16 including a tension member 18 and oppositely disposed anchors 20. Splint 16 as shown in FIG. 1 has been positioned to draw opposite walls of left ventricle 10 toward each other to reduce the “radius” of the left ventricular cross-section or the cross-sectional area thereof to reduce left ventricular wall stresses. It should be understood that although the splint 16 and the alternative devices disclosed herein are described in relation to the left ventricle of a human heart, these devices could also be used to reduce the radius or cross-sectional area of the other chambers of a human heart in transverse or vertical directions, or at an angle between the transverse and vertical.
  • [0032]
    [0032]FIG. 2 discloses an alternate embodiment of the present invention, wherein a balloon 200 is deployed adjacent the left ventricle. The size and degree of inflation of the balloon can be varied to reduce the radius or cross-sectional area of left ventricle 10 of heart 14.
  • [0033]
    [0033]FIG. 3 shows yet another alternative embodiment of the present invention deployed with respect to left ventricle 10 of human heart 14. Here a compression frame structure 300 is engaged with heart 14 at atraumatic anchor pads 310. A compression member 312 having an atraumatic surface 314 presses against a wall of left ventricle 10 to reduce the radius or cross-sectional area thereof.
  • [0034]
    [0034]FIG. 4 is a transverse cross-sectional view of human heart 14 showing yet another embodiment of the present invention. In this case a clamp 400 having atraumatic anchor pads 410 biased toward each other is shown disposed on a wall of left ventricle 10. Here the radius or cross-sectional area of left ventricle 10 is reduced by clamping off the portion of the wall between pads 410. Pads 410 can be biased toward each other and/or can be held together by a locking device.
  • [0035]
    Each of the various embodiments of the present invention disclosed in FIGS. 1-4 can be made from materials which can remain implanted in the human body indefinitely. Such biocompatible materials are well-known to those skilled in the art of clinical medical devices.
  • [0036]
    [0036]FIG. 5 shows an alternate embodiment of the splint of FIG. 1 referred to in FIG. 5 by the numeral 116. The embodiment 116 shown in FIG. 5 includes three tension members 119 as opposed to a single tension member 18 as shown in FIG. 1. FIG. 6 shows yet another embodiment of the splint 216 having four tension members 218. It is anticipated that in some patients, the disease process of the failing heart may be so advanced that three, four or more tension members may be desirable to reduce the heart wall stresses more substantially than possible with a single tension member as shown in FIG. 1.
  • [0037]
    [0037]FIG. 7 is a partial vertical cross-section of human heart 14 showing left ventricle 10 and left atrium 22. As shown in FIG. 7, heart 14 includes a region of scar tissue 24 associated with an aneurysm or ischemia. As shown in FIG. 7, the scar tissue 24 increases the radius or cross-sectional area of left ventricle 10 in the region affected by the scar tissue. Such an increase in the radius or cross-sectional area of the left ventricle will result in greater wall stresses on the walls of the left ventricle.
  • [0038]
    [0038]FIG. 8 is a vertical cross-sectional view of the heart 14 as shown in FIG. 7, wherein a splint 16 has been placed to draw the scar tissue 24 toward an opposite wall of left ventricle 10. As a consequence of placing splint 16, the radius or cross-sectional area of the left ventricle affected by the scar tissue 24 is reduced. The reduction of this radius or cross-sectional area results in reduction in the wall stress in the left ventricular wall and thus improves heart pumping efficiency.
  • [0039]
    [0039]FIG. 9 is a vertical cross-sectional view of left ventricle 10 and left atrium 22 of heart 14 in which a splint 16 has been placed. As shown in FIG. 9, splint 16 includes an alternative anchor 26. The anchor 26 is preferably an elongate member having a length as shown in FIG. 9 substantially greater than its width (not shown). Anchor bar 26 might be used to reduce the radius or cross-sectional area of the left ventricle in an instance where there is generalized enlargement of left ventricle 10 such as in idiopathic dilated cardiomyopathy. In such an instance, bar anchor 26 can distribute forces more widely than anchor 20.
  • [0040]
    [0040]FIGS. 10 and 11 are side views of a hinged anchor 28 which could be substituted for anchors 20 in undeployed and deployed positions respectively. Anchor 28 as shown in FIG. 10 includes two legs similar to bar anchor 26. Hinged anchor 28 could include additional legs and the length of those legs could be varied to distribute the force over the surface of the heart wall. In addition there could be webbing between each of the legs to give anchor 28 an umbrella-like appearance. Preferably the webbing would be disposed on the surface of the legs which would be in contact with the heart wall.
  • [0041]
    [0041]FIG. 12 is a cross-sectional view of a capture ball anchor 30. Capture ball anchor 30 can be used in place of anchor 20. Capture ball anchor 30 includes a disk portion 32 to distribute the force of the anchor on the heart wall, and a recess 34 for receiving a ball 36 affixed to an end of tension member 18. Disk 32 and recess 34 include a side groove which allows tension member 38 to be passed from an outside edge of disk 32 into recess 34. Ball 36 can then be advanced into recess 34 by drawing tension member 18 through an opening 38 in recess 34 opposite disk 32.
  • [0042]
    [0042]FIG. 13 is a perspective view of a cross bar anchor 40. The cross bar anchor 40 can be used in place of anchors 20. The anchor 40 preferably includes a disk or pad portion 42 having a cross bar 44 extending over an opening 46 in pad 42. Tension member 18 can be extended through opening 46 and tied to cross bar 42 as shown.
  • [0043]
    In use, the various embodiments of the present invention are placed in or adjacent the human heart to reduce the radius or cross-section area of at least one chamber of the heart. This is done to reduce wall stress or tension in the heart or chamber wall to slow, stop or reverse failure of the heart. In the case of the splint 16 shown in FIG. 1, a canula can be used to pierce both walls of the heart and one end of the splint can be advanced through the canula from one side of the heart to the opposite side where an anchor can be affixed or deployed. Likewise, an anchor is affixed or deployed at the opposite end of splint 16.
  • [0044]
    [0044]FIG. 14 is a view of a cylinder or idealized heart chamber 48 which is used to illustrate the reduction of wall stress in a heart chamber as a result of deployment of the splint in accordance with the present invention. The model used herein and the calculations related to this model are intended merely to illustrate the mechanism by which wall stress is reduced in the heart chamber. No effort is made herein to quantify the actual reduction which would be realized in any particular in vivo application.
  • [0045]
    [0045]FIG. 15 is a view of the idealized heart chamber 48 of FIG. 14 wherein the chamber has been splinted along its length L such that a “figure eight” cross-section has been formed along the length thereof. It should be noted that the perimeter of the circular transverse cross-section of the chamber in FIG. 14 is equal to the perimeter of the figure eight transverse cross-section of FIG. 15. For purposes of this model, opposite lobes of the figure in cross-section are assumed to be mirror images.
  • [0046]
    [0046]FIG. 16 shows various parameters of the FIG. 8 cross-section of the splinted idealized heart chamber of FIG. 15. Where l is the length of the splint between opposite walls of the chamber, R2 is the radius of each lobe, θ is the angle between the two radii of one lobe which extends to opposite ends of the portion of the splint within chamber 48 and h is the height of the triangle formed by the two radii and the portion of the splint within the chamber 48 (R1 is the radius of the cylinder of FIG. 14). These various parameters are related as follows:
  • [0047]
    h<R2 COS (θ/2)
  • [0048]
    l=R2 SIN (θ/2)
  • [0049]
    R2=R1π/(2π−θ)
  • [0050]
    From these relationships, the area of the figure eight cross-section can be calculated by:
  • A 2−2π(R 2)2(1−θ/2π)+hl
  • [0051]
    Where chamber 48 is unsplinted as shown in FIG. 14 A1, the original cross-sectional area of the cylinder is equal to A2 where θ=180, h=0 and l=2R2. Volume equals A2 times length L and circumferential wall tension equals pressure within the chamber times R2 times the length L of the chamber.
  • [0052]
    Thus, for example, with an original cylindrical radius of four centimeters and a pressure within the chamber of 140 mm of mercury, the wall tension T in the walls of the cylinder is 104.4 newtons. When a 3.84 cm splint is placed as shown in FIGS. 15 and 16 such that l=3.84 cm, the wall tension T is 77.33 newtons.
  • [0053]
    [0053]FIGS. 17 and 18 show a hypothetical distribution of wall tension T and pressure P for the figure eight cross-section. As θ goes from 180 to 0, tension Ts in the splint goes from 0 to a 2T load where the chamber walls carry a T load.
  • [0054]
    It will be understood that this disclosure, in many respects, is only illustrative. Changes may be made in details, particularly in matters of shape, size, material, and arrangement of parts without exceeding the scope of the invention. Accordingly, the scope of the invention is as defined in the language of the appended claims.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US963899 *Nov 6, 1909Jul 12, 1910Samuel L. KistlerSurgical clamp.
US3019790 *Jul 15, 1960Feb 6, 1962Militana Robert JCombination hemostat and intravenous needle
US3656185 *Feb 4, 1970Apr 18, 1972Rhone Poulenc SaCardiac valvular support prosthesis
US3980086 *Jul 18, 1975Sep 14, 1976Bio-Medicus, Inc.Fluid conveying surgical instrument
US4035849 *Jun 25, 1976Jul 19, 1977William W. AngellHeart valve stent and process for preparing a stented heart valve prosthesis
US4055861 *Apr 9, 1976Nov 1, 1977Rhone-Poulenc IndustriesSupport for a natural human heart valve
US4217665 *Jun 22, 1976Aug 19, 1980Societe D'utilisation Scientifique Et Industrielle Du Froid - UsifroidProsthesis for use in valvuloplasty
US4300564 *Nov 1, 1979Nov 17, 1981Olympus Optical Co., Ltd.Forceps for extracting stones in the pelvis of a kidney
US4306319 *Jun 16, 1980Dec 22, 1981Robert L. KasterHeart valve with non-circular body
US4343048 *Aug 4, 1980Aug 10, 1982Ross Donald NStent for a cardiac valve
US4579120 *Jan 29, 1985Apr 1, 1986Cordis CorporationStrain relief for percutaneous lead
US4592342 *Jan 3, 1984Jun 3, 1986Salmasian Samuel SMethod for appetite suppression and weight loss maintenance and device
US4629459 *Dec 28, 1983Dec 16, 1986Shiley Inc.Alternate stent covering for tissue valves
US4632101 *Jan 31, 1985Dec 30, 1986Yosef FreedlandOrthopedic fastener
US5061277 *Sep 2, 1988Oct 29, 1991Baxter International Inc.Flexible cardiac valvular support prosthesis
US5156621 *Mar 15, 1991Oct 20, 1992Navia Jose AStentless bioprosthetic cardiac valve
US5256132 *Aug 17, 1992Oct 26, 1993Snyders Robert VCardiac assist envelope for endoscopic application
US5258015 *May 3, 1991Nov 2, 1993American Cyanamid CompanyLocking filament caps
US5300087 *Jan 26, 1993Apr 5, 1994Knoepfler Dennis JMultiple purpose forceps
US5312642 *Mar 5, 1993May 17, 1994United States Surgical CorporationMethod and apparatus for calendering and coating/filling sutures
US5360444 *Dec 9, 1993Nov 1, 1994Kenji KusuharaOccluder supporter and a method of attachment thereof
US5376112 *Mar 19, 1993Dec 27, 1994Duran; Carlos G.Valveless conduit with sigmoid valve annuloplasty ring
US5383840 *Jul 28, 1992Jan 24, 1995Vascor, Inc.Biocompatible ventricular assist and arrhythmia control device including cardiac compression band-stay-pad assembly
US5389096 *Feb 25, 1993Feb 14, 1995Advanced Cardiovascular SystemsSystem and method for percutaneous myocardial revascularization
US5397331 *Nov 25, 1992Mar 14, 1995Cook IncorporatedSupporting device and apparatus for inserting the device
US5417709 *Apr 12, 1994May 23, 1995Symbiosis CorporationEndoscopic instrument with end effectors forming suction and/or irrigation lumens
US5445600 *Apr 29, 1994Aug 29, 1995Abdulla; Ra-IdFlow control systemic to pulmonary arterial shunt
US5450860 *Aug 31, 1993Sep 19, 1995W. L. Gore & Associates, Inc.Device for tissue repair and method for employing same
US5522884 *Feb 19, 1993Jun 4, 1996Medtronic, Inc.Holder for adjustable mitral & tricuspid annuloplasty rings
US5571215 *Dec 6, 1993Nov 5, 1996Heartport, Inc.Devices and methods for intracardiac procedures
US5607471 *Aug 21, 1995Mar 4, 1997Jacques SeguinProsthetic ring for heart surgery
US5655548 *Sep 16, 1996Aug 12, 1997Circulation, Inc.Method for treatment of ischemic heart disease by providing transvenous myocardial perfusion
US5665092 *Dec 1, 1995Sep 9, 1997Mangiardi; John R.Marker for surgical procedures
US5674279 *Jun 29, 1995Oct 7, 1997Medtronic, Inc.Annuloplasty and suture rings
US5713954 *Jun 13, 1995Feb 3, 1998Abiomed R&D, Inc.Extra cardiac ventricular assist device
US5738649 *Apr 16, 1996Apr 14, 1998Cardeon CorporationPeripheral entry biventricular catheter system for providing access to the heart for cardiopulmonary surgery or for prolonged circulatory support of the heart
US5766234 *Apr 16, 1996Jun 16, 1998Light Sciences Limited PartnershipImplanting and fixing a flexible probe for administering a medical therapy at a treatment site within a patient'body
US5807384 *Dec 20, 1996Sep 15, 1998Eclipse Surgical Technologies, Inc.Transmyocardial revascularization (TMR) enhanced treatment for coronary artery disease
US5824066 *May 21, 1997Oct 20, 1998Medtronic, Inc.Annuloplasty prosthesis
US5824069 *Oct 27, 1997Oct 20, 1998Medtronic, Inc.Prosthetic heart valve with suturing member having non-uniform radial width
US5840059 *Jun 7, 1995Nov 24, 1998Cardiogenesis CorporationTherapeutic and diagnostic agent delivery
US5876436 *Feb 13, 1997Mar 2, 1999St. Jude Medical, Inc.Rotatable cuff assembly for a heart valve prosthesis
US5888240 *Dec 3, 1996Mar 30, 1999Baxter International Inc.Distensible annuloplasty ring for surgical remodelling of an atrioventricular valve and nonsurgical method for post-implantation distension thereof to accomodate patient growth
US5957977 *Jan 2, 1996Sep 28, 1999University Of CincinnatiActivation device for the natural heart including internal and external support structures
US5984917 *Oct 1, 1997Nov 16, 1999Ep Technologies, Inc.Device and method for remote insertion of a closed loop
US5999678 *Dec 27, 1996Dec 7, 1999Eclipse Surgical Technologies, Inc.Laser delivery means adapted for drug delivery
US6050936 *Jan 2, 1997Apr 18, 2000Myocor, Inc.Heart wall tension reduction apparatus
US6129758 *Oct 3, 1996Oct 10, 2000Cardiomend LlcProducts and methods for circulatory system valve repair
US6132438 *Jun 7, 1995Oct 17, 2000Ep Technologies, Inc.Devices for installing stasis reducing means in body tissue
US6162168 *Jan 28, 2000Dec 19, 2000Myocor, Inc.Heart wall tension reduction apparatus
US6206004 *Dec 6, 1996Mar 27, 2001Comedicus IncorporatedTreatment method via the pericardial space
US6332863 *Oct 27, 2000Dec 25, 2001Myocor, Inc.Heart wall tension reduction kit
US6379366 *Mar 13, 2000Apr 30, 2002Ep Technologies, Inc.Devices for installing stasis reducing means in body tissue
US6406420 *Oct 21, 1999Jun 18, 2002Myocor, Inc.Methods and devices for improving cardiac function in hearts
US6508756 *Dec 30, 1998Jan 21, 2003Abiomed, Inc.Passive cardiac assistance device
US6514194 *Nov 2, 2001Feb 4, 2003Myocor, Inc.Heart wall tension reduction apparatus and method
US6520904 *Jun 4, 1999Feb 18, 2003The University Of CincinnatiDevice and method for restructuring heart chamber geometry
US6544180 *Nov 30, 1999Apr 8, 2003Data Sciences International, Inc.Blood flow meter apparatus and method of use
US6572529 *Jul 6, 2001Jun 3, 2003Wilk Patent Development CorporationIntrapericardial assist method
US6589160 *Nov 2, 2001Jul 8, 2003Myocor, Inc.Heart wall tension reduction apparatus
US6645139 *May 7, 2002Nov 11, 2003Acorn Cardiovascular Inc.Bag for at least partially enveloping a heart
US6651671 *Oct 12, 1999Nov 25, 2003Heartport, Inc.Lens-invasive devices and methods for cardiac valve surgery
US6755777 *Dec 20, 2002Jun 29, 2004Myocor, Inc.Heart wall tension reduction apparatus and method
US6814700 *Mar 16, 2000Nov 9, 2004Heartport, Inc.Soft tissue retractor and method for providing surgical access
US6893392 *Feb 13, 2003May 17, 2005Acorn Cardiovascular, Inc.Cardiac reinforcement device
US7163507 *Sep 23, 2003Jan 16, 2007Acorn Cardiovascular, Inc.Cardiac reinforcement device
US7166071 *Sep 23, 2003Jan 23, 2007Acorn Cardiovascular, Inc.Cardiac reinforcement device
US7189199 *May 2, 2002Mar 13, 2007Myocor, Inc.Methods and devices for improving cardiac function in hearts
US7255674 *Sep 26, 2003Aug 14, 2007Acorn Cardiovascular, Inc.Cardiac reinforcement device
US7261684 *Sep 26, 2003Aug 28, 2007Acorn Cardiovascular, Inc.Cardiac reinforcement device
US7278964 *Mar 5, 2004Oct 9, 2007Acorn Cardiovascular, Inc.Cardiac reinforcement device
US20010021874 *Feb 16, 2001Sep 13, 2001Alexandre CarpentierExpandable annuloplasty ring
US20020007216 *May 7, 2001Jan 17, 2002Melvin David BoydHeart wall actuation device for the natural heart
US20020022880 *Apr 13, 2001Feb 21, 2002Melvin David B.Device and method for restructuring heart chamber geometry
US20020029783 *Sep 12, 2001Mar 14, 2002Stevens John H.Minimally-invasive devices and methods for treatment of congestive heart failure
US20020058855 *Nov 2, 2001May 16, 2002Myocor, Inc.Heart wall tension reduction apparatus and method
US20020091296 *Feb 25, 2002Jul 11, 2002Acorn Cardiovascular, Inc.Cardiac reinforcement device
US20020111533 *Jan 22, 2002Aug 15, 2002Melvin David BoydDevice and method for restructuring heart chamber geometry
US20020111636 *Mar 15, 2002Aug 15, 2002Fleischman Sidney D.Devices for installing stasis reducing means in body tissue
US20020169359 *May 2, 2002Nov 14, 2002Myocor, Inc.Methods and devices for improving cardiac function in hearts
US20030149333 *Feb 13, 2003Aug 7, 2003Acorn Cardiovascular, Inc.Cardiac reinforcement device
US20030166992 *Dec 20, 2002Sep 4, 2003Myocor, Inc.Heart wall tension reduction apparatus
US20030171641 *Dec 20, 2002Sep 11, 2003Myocor, IncHeart wall tension reduction apparatus and method
US20040024286 *Jul 14, 2003Feb 5, 2004The University Of CincinnatiHeart wall actuation device for the natural heart
US20040059181 *Sep 23, 2003Mar 25, 2004Acorn Cardiovascular, Inc.Cardiac reinforcement device
US20040059182 *Sep 23, 2003Mar 25, 2004Acorn Cardiovascular, Inc.Cardiac reinforcement device
US20040059187 *Sep 23, 2003Mar 25, 2004Acorn Cardiovascular, Inc.Cardiac reinforcement device
US20040059188 *Sep 26, 2003Mar 25, 2004Acorn Cardiovascula, Inc.Cardiac reinforcement device
US20040059189 *Sep 26, 2003Mar 25, 2004Acorn Cardiovascular, Inc.Cardiac reinforcement device
US20040133063 *Dec 12, 2003Jul 8, 2004MyocorMethods and devices for improving cardiac function in hearts
US20040167374 *Feb 17, 2004Aug 26, 2004Myocor, Inc.Heart wall tension reduction apparatus and method
US20040171909 *Mar 5, 2004Sep 2, 2004Acron Cardiovascular, Inc.Cardiac reinforcement device
US20040181124 *Mar 26, 2004Sep 16, 2004Acorn Cardiovascular, Inc.Cardiac reinforcement device
US20040267083 *Dec 17, 2003Dec 30, 2004MyocorMethods and devices for improving cardiac function in hearts
US20060161040 *Dec 23, 2005Jul 20, 2006Myocor, Inc.Methods and devices for improving cardiac function in hearts
US20070004962 *Aug 31, 2006Jan 4, 2007Acorn Cardiovascular, Inc.Cardiac support device with differential compliance
US20070112244 *Apr 14, 2006May 17, 2007Myocor, Inc.Methods and devices for improving cardiac function in hearts
US20070225547 *May 18, 2007Sep 27, 2007Acorn Cardiovascular, Inc.Collapsible delivery tool for cardiac support device
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US6595912Sep 14, 2001Jul 22, 2003Paracor Surgical, Inc.Expandable cardiac harness for treating congestive heart failure
US6602184Sep 10, 2001Aug 5, 2003Paracor Surgical, Inc.Expandable cardiac harness for treating congestive heart failure
US6612978Sep 10, 2001Sep 2, 2003Paracor Surgical, Inc.Expandable cardiac harness for treating congestive heart failure
US6612979Sep 14, 2001Sep 2, 2003Paracor Surgical, Inc.Expandable cardiac harness for treating congestive heart failure
US6663558Sep 10, 2001Dec 16, 2003Paracor Surgical, Inc.Expandable cardiac harness for treating congestive heart failure
US6682474Sep 10, 2001Jan 27, 2004Paracor Surgical, Inc.Expandable cardiac harness for treating congestive heart failure
US6702732Aug 8, 2000Mar 9, 2004Paracor Surgical, Inc.Expandable cardiac harness for treating congestive heart failure
US7316706Jun 14, 2004Jan 8, 2008Medtronic Vascular, Inc.Tensioning device, system, and method for treating mitral valve regurgitation
US7374530Feb 17, 2005May 20, 2008Benvenue Medical Inc.Catheter-based tissue remodeling devices and methods
US7452325Feb 17, 2005Nov 18, 2008Benvenue Medical Inc.Catheter-based tissue remodeling devices and methods
US7678135Apr 14, 2006Mar 16, 2010Usgi Medical, Inc.Compressible tissue anchor assemblies
US7695493Jun 9, 2004Apr 13, 2010Usgi Medical, Inc.System for optimizing anchoring force
US7703459Sep 29, 2004Apr 27, 2010Usgi Medical, Inc.Apparatus and methods for mapping out endoluminal gastrointestinal surgery
US7704264Nov 17, 2004Apr 27, 2010Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue folds
US7736299Jul 21, 2005Jun 15, 2010Paracor Medical, Inc.Introducer for a cardiac harness delivery
US7736374Mar 1, 2005Jun 15, 2010Usgi Medical, Inc.Tissue manipulation and securement system
US7736378May 7, 2004Jun 15, 2010Usgi Medical, Inc.Apparatus and methods for positioning and securing anchors
US7736379Jul 11, 2005Jun 15, 2010Usgi Medical, Inc.Compressible tissue anchor assemblies
US7744613Dec 12, 2003Jun 29, 2010Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue folds
US7766816Aug 3, 2010Chf Technologies, Inc.Method and apparatus for closing off a portion of a heart ventricle
US7918845Nov 16, 2004Apr 5, 2011Usgi Medical, Inc.Endoluminal tool deployment system
US7918869Apr 5, 2011Usgi Medical, Inc.Methods and apparatus for performing endoluminal gastroplasty
US7942884Jul 1, 2003May 17, 2011Usgi Medical, Inc.Methods for reduction of a gastric lumen
US7942898Jul 1, 2003May 17, 2011Usgi Medical, Inc.Delivery systems and methods for gastric reduction
US7955340Dec 12, 2003Jun 7, 2011Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue folds
US7976454Aug 28, 2006Jul 12, 2011Paracor Medical, Inc.Cardiac harness
US8057511Nov 15, 2011Usgi Medical, Inc.Apparatus and methods for positioning and securing anchors
US8066719Nov 18, 2004Nov 29, 2011Ewers Richard CApparatus and methods for forming gastrointestinal tissue approximations
US8092363Sep 5, 2007Jan 10, 2012Mardil, Inc.Heart band with fillable chambers to modify heart valve function
US8092367Jan 10, 2012Mardil, Inc.Method for external stabilization of the base of the heart
US8128553Dec 12, 2006Mar 6, 2012Mardil, Inc.Method and apparatus for external stabilization of the heart
US8192351Sep 23, 2009Jun 5, 2012Paracor Medical, Inc.Medical device delivery system having integrated introducer
US8206417Jun 26, 2012Usgi Medical Inc.Apparatus and methods for optimizing anchoring force
US8216252Jul 10, 2012Usgi Medical, Inc.Tissue manipulation and securement system
US8216253Jul 10, 2012Usgi Medical, Inc.Apparatus for manipulating and securing tissue
US8216260Aug 25, 2008Jul 10, 2012Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue folds
US8236009Oct 14, 2009Aug 7, 2012Usgi Medical, Inc.Needle assembly for tissue manipulation
US8257394Sep 4, 2012Usgi Medical, Inc.Apparatus and methods for positioning and securing anchors
US8262676Sep 18, 2009Sep 11, 2012Usgi Medical, Inc.Apparatus and methods for forming gastrointestinal tissue approximations
US8287557Oct 16, 2012Guided Delivery Systems, Inc.Methods and devices for termination
US8298291Oct 30, 2012Usgi Medical, Inc.Methods and apparatus for securing and deploying tissue anchors
US8308765Nov 13, 2012Usgi Medical, Inc.Apparatus and methods for positioning and securing anchors
US8333777Apr 21, 2006Dec 18, 2012Benvenue Medical, Inc.Catheter-based tissue remodeling devices and methods
US8343173Jan 1, 2013Guided Delivery Systems Inc.Delivery devices and methods for heart valve repair
US8343175Apr 26, 2010Jan 1, 2013Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue folds
US8382800Mar 15, 2010Feb 26, 2013Usgi Medical, Inc.Compressible tissue anchor assemblies
US8388680Oct 18, 2006Mar 5, 2013Guided Delivery Systems, Inc.Methods and devices for catheter advancement and delivery of substances therethrough
US8391996Aug 17, 2009Mar 5, 2013Benvenue Medical, Inc.Catheter-based tissue remodeling devices and methods
US8394008Jul 29, 2010Mar 12, 2013Bioventrix, Inc.Steerable lesion excluding heart implants for congestive heart failure
US8425402Apr 23, 2013Bioventrix, Inc.Cardiac anchor structures, methods, and systems for treatment of congestive heart failure and other conditions
US8444657Apr 28, 2005May 21, 2013Usgi Medical, Inc.Apparatus and methods for rapid deployment of tissue anchors
US8449442May 28, 2013Bioventrix, Inc.Method and device for percutaneous left ventricular reconstruction
US8465500Jan 19, 2006Jun 18, 2013Mayo Foundation For Medical Education And ResearchThorascopic heart valve repair method and apparatus
US8491455Oct 3, 2008Jul 23, 2013Bioventrix, Inc.Treating dysfunctional cardiac tissue
US8506474Aug 21, 2006Aug 13, 2013Bioventrix, Inc.Method and device for treating dysfunctional cardiac tissue
US8574243Dec 12, 2003Nov 5, 2013Usgi Medical, Inc.Apparatus and methods for forming and securing gastrointestinal tissue folds
US8636639Jan 24, 2012Jan 28, 2014Bioventrix, Inc.Signal transmitting and lesion excluding heart implants for pacing, defibrillating, and/or sensing of heart beat
US8715160Feb 6, 2012May 6, 2014Mardil, Inc.Method and apparatus for external stabilization of the heart
US8726909Jan 27, 2006May 20, 2014Usgi Medical, Inc.Methods and apparatus for revision of obesity procedures
US8740940Jan 23, 2013Jun 3, 2014Usgi Medical, Inc.Compressible tissue anchor assemblies
US8758393Oct 20, 2008Jun 24, 2014Neochord, Inc.Minimally invasive repair of a valve leaflet in a beating heart
US8790367Feb 5, 2009Jul 29, 2014Guided Delivery Systems Inc.Multi-window guide tunnel
US8795298Oct 9, 2009Aug 5, 2014Guided Delivery Systems Inc.Tether tensioning devices and related methods
US8828027Jun 14, 2010Sep 9, 2014U.S.G.I. Medical, Inc.Tissue manipulation and securement system
US8870916Jul 5, 2007Oct 28, 2014USGI Medical, IncLow profile tissue anchors, tissue anchor systems, and methods for their delivery and use
US8926634Dec 5, 2007Jan 6, 2015Usgi Medical, Inc.Apparatus and methods for manipulating and securing tissue
US8968175Jul 23, 2013Mar 3, 2015Bioventrix, Inc.Treating dysfunctional cardiac tissue
US8968338Feb 19, 2010Mar 3, 2015Mayo Foundation For Medical Education And ResearchThorascopic heart valve repair method and apparatus
US8979750Sep 30, 2012Mar 17, 2015Bioventrix, Inc.Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions
US8986189Jul 1, 2010Mar 24, 2015Bioventrix, Inc.Method and apparatus for closing off a portion of a heart ventricle
US9039594Jan 28, 2014May 26, 2015Bioventrix, Inc.Signal transmitting and lesion excluding heart implants for pacing, defibrillating, and/or sensing of heart beat
US9044221Dec 29, 2011Jun 2, 2015Neochord, Inc.Exchangeable system for minimally invasive beating heart repair of heart valve leaflets
US9044231Mar 11, 2013Jun 2, 2015Bioventrix, Inc.Steerable lesion excluding heart implants for congestive heart failure
US9072513Aug 6, 2008Jul 7, 2015Guided Delivery Systems Inc.Methods and devices for termination
US9095363Sep 30, 2012Aug 4, 2015Bioventrix, Inc.Remote pericardial hemostasis for ventricular access and reconstruction or other organ therapies
US9107658Dec 12, 2012Aug 18, 2015Benvenue Medical, Inc.Catheter-based tissue remodeling devices and methods
US9119720May 20, 2013Sep 1, 2015Bioventrix, Inc.Method and device for percutaneous left ventricular reconstruction
US9125632Oct 17, 2008Sep 8, 2015Guided Delivery Systems, Inc.Systems and methods for cardiac remodeling
US9173711Sep 30, 2012Nov 3, 2015Bioventrix, Inc.Cardiac implant migration inhibiting systems
US9173712Sep 30, 2012Nov 3, 2015Bioventrix, Inc.Over-the-wire cardiac implant delivery system for treatment of CHF and other conditions
US9192374Oct 20, 2008Nov 24, 2015Neochord, Inc.Minimally invasive repair of a valve leaflet in a beating heart
US9211115May 21, 2007Dec 15, 2015Bioventrix, Inc.Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states
US9226825Jul 27, 2004Jan 5, 2016Guided Delivery Systems, Inc.Delivery devices and methods for heart valve repair
US9259319Aug 13, 2013Feb 16, 2016Bioventrix, Inc.Method and device for treating dysfunctional cardiac tissue
US9265514Apr 17, 2012Feb 23, 2016Miteas Ltd.Manipulator for grasping tissue
US9289298Mar 17, 2014Mar 22, 2016Mardil, Inc.Method and apparatus for external stabilization of the heart
US9320513Mar 13, 2015Apr 26, 2016Bioventrix, Inc.Trans-catheter ventricular reconstruction structures, methods, and systems for treatment of congestive heart failure and other conditions
US9364213May 21, 2013Jun 14, 2016Mayo Foundation For Medical Education And ResearchThorascopic heart valve repair method
US9370425Oct 14, 2013Jun 21, 2016Mardil, Inc.Cardiac treatment system and method
US9402722May 27, 2015Aug 2, 2016Bioventrix, Inc.Steerable lesion excluding heart implants for congestive heart failure
US9421101Oct 14, 2013Aug 23, 2016Mardil, Inc.Cardiac treatment system
US9421102Oct 14, 2013Aug 23, 2016Mardil, Inc.Cardiac treatment system and method
US20020019580 *Sep 10, 2001Feb 14, 2002Lilip LauExpandable cardiac harness for treating congestive heart failure
US20030065248 *Dec 9, 2002Apr 3, 2003Lilip LauCardiac treatment apparatus
US20040260317 *Jun 14, 2004Dec 23, 2004Elliot BloomTensioning device, system, and method for treating mitral valve regurgitation
US20040267329 *Mar 8, 2004Dec 30, 2004Mardil, Inc.Method and apparatus for external heart stabilization
US20060089711 *Sep 22, 2005Apr 27, 2006Medtronic Vascular, Inc.Multifilament anchor for reducing a compass of a lumen or structure in mammalian body
US20060106403 *Feb 17, 2005May 18, 2006Laurent SchallerCatheter-based tissue remodeling devices and methods
US20060135966 *Feb 17, 2005Jun 22, 2006Laurent SchallerCatheter-based tissue remodeling devices and methods
US20060135968 *Feb 17, 2005Jun 22, 2006Laurent SchallerCatheter-based tissue remodeling devices and methods
US20060135970 *Feb 17, 2005Jun 22, 2006Laurent SchallerCatheter-based tissue remodeling devices and methods
US20070025009 *Jul 19, 2006Feb 1, 2007Fuji Photo Film Co., Ltd.Magnetic recorder
US20070049971 *Jun 8, 2006Mar 1, 2007Sing-Fatt ChinMethod and apparatus for closing off a portion of a heart ventricle
US20070055206 *Aug 10, 2005Mar 8, 2007Guided Delivery Systems, Inc.Methods and devices for deployment of tissue anchors
US20070066863 *Aug 31, 2006Mar 22, 2007Medtronic Vascular, Inc.Device for treating mitral valve regurgitation
US20070073274 *Aug 21, 2006Mar 29, 2007Sing-Fatt ChinMethod and device for treating dysfunctional cardiac tissue
US20070203391 *Feb 23, 2007Aug 30, 2007Medtronic Vascular, Inc.System for Treating Mitral Valve Regurgitation
US20070265658 *May 12, 2006Nov 15, 2007Aga Medical CorporationAnchoring and tethering system
US20080097148 *Dec 20, 2007Apr 24, 2008Chf Technologies, Inc.Method and device for percutaneous left ventricular reconstruction
US20080172035 *Oct 18, 2006Jul 17, 2008Starksen Niel FMethods and devices for catheter advancement and delivery of substances therethrough
US20080294251 *May 21, 2007Nov 27, 2008Bioventrix (A Chf Technologies' Company)Location, time, and/or pressure determining devices, systems, and methods for deployment of lesion-excluding heart implants for treatment of cardiac heart failure and other disease states
US20090062596 *Sep 5, 2007Mar 5, 2009Leinsing Karl RHeart band with fillable chambers to modify heart valve function
US20090093670 *Oct 3, 2008Apr 9, 2009Bioventrix (A Chf Technologies, Inc.)Treating Dysfunctional Cardiac Tissue
US20090234318 *Oct 17, 2008Sep 17, 2009Guided Delivery Systems, Inc.Systems and methods for cardiac remodeling
US20100016655 *Jan 21, 2010Bio Ventrix (a CHF Technologies, Inc.Cardiac Anchor Structures, Methods, and Systems for Treatment of Congestive Heart Failure and Other Conditions
US20100094314 *Oct 9, 2009Apr 15, 2010Hernlund Jonathan DTether tensioning devices and related methods
US20100268020 *Jul 1, 2010Oct 21, 2010Bioventrix (A Chf Technologies, Inc.)Method and Apparatus For Closing Off a Portion of a Heart Ventricle
US20110160750 *Jul 29, 2010Jun 30, 2011BioVentrix (a CHF Technologies Company)Steerable Lesion Excluding Heart Implants For Congestive Heart Failure
USD717954Oct 14, 2013Nov 18, 2014Mardil, Inc.Heart treatment device
Classifications
U.S. Classification600/16
International ClassificationA61B17/12, A61M31/00, A61B19/00, A61F2/02, A61N1/362, A61F2/00, A61B17/122, A61B17/04, A61B17/00
Cooperative ClassificationY10S623/91, A61B2017/048, A61B17/1227, A61B2017/0404, A61B2017/0496, A61B2017/00243, A61B2017/0461, A61F2/2487, A61B2017/0435, A61F2/2481, A61B17/00234, A61B2017/0417, A61B2017/0429
European ClassificationA61F2/24W4, A61B17/00E
Legal Events
DateCodeEventDescription
Sep 5, 2007ASAssignment
Owner name: VENTURE LENDING & LEASING IV, INC., CALIFORNIA
Free format text: SECURITY AGREEMMENT;ASSIGNOR:MYOCOR, INC.;REEL/FRAME:019805/0072
Effective date: 20070820
Owner name: VENTURE LENDING & LEASING IV, INC.,CALIFORNIA
Free format text: SECURITY AGREEMMENT;ASSIGNOR:MYOCOR, INC.;REEL/FRAME:019805/0072
Effective date: 20070820
Feb 16, 2009ASAssignment
Owner name: EDWARDS LIFESCIENCES LLC, CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MYOCOR, INC.;REEL/FRAME:022277/0011
Effective date: 20081029
Owner name: EDWARDS LIFESCIENCES LLC,CALIFORNIA
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MYOCOR, INC.;REEL/FRAME:022277/0011
Effective date: 20081029